Switzerland’s president is lobbying Trump administration officials in Washington this week, as concern mounts over the double ...

Roche is working to mitigate potential impacts from tariffs by moving production of its medicines to the U.S. and petitioning ...

Granite will focus on two antibody therapies, both targeting crucial players in the inflammatory cascade to address ...

In today's Pharmalittle roundup, we're reading about Roche and Merck struggles with tariffs, NEJM quizzed by U.S. attorney, ...

U.S. drugmakers Bristol Myers and Merck & Co, and their European counterparts Sanofi and Roche all reported first-quarter ...

Clinical-stage company targeting fundamental drivers of inflammation, autoimmunity and fibrosis, founded by Versant Ventures and Novartis Venture Fund- ...

Brabeck-Letmathe, 80, spent his career at Nestlé. He became a controversial figure after sharing his views on water as a ...

The pharmaceutical and diagnostics company slightly exceeded expectations in the first quarter, driven by its pharmaceutical ...

Roche has said it is petitioning the Trump administration for an exemption from threatened tariffs for pharmaceuticals, ...

Two of Europe’s biggest drugmakers said they’re looking at ways to protect themselves from US President Donald Trump’s ...

During the three-day visit, the Swiss delegation will highlight Switzerland’s substantial investments in the United States, ...

FRANKFURT (Reuters) -Swiss drugmaker Roche said on Thursday its first-quarter sales rose a forecast-beating 7% driven by ...